Am J Transplant, Volume 21, Suppl 3 Archives - Page 66 of 139 - ATC Abstracts

2021 American Transplant Congress
Tru and Sure -A Tale of Two Cities! Can Allosure Predict and Enhance Trugraf Results?
Y. A. Qazi¹, W. Mon¹, S. Qazi², C. Choi¹, M. Smogorzewski¹
¹Keck Medical Center at USC, Los Angeles, CA, ²Keck Medical Center at USC, La Canada Flt, CA
*Purpose: With the introduction of Cell free DNA(cfDNA) technology in transplantation a few years ago, and a more recent addition of genomic testing with TruGraf…
2021 American Transplant Congress
Estimated GFR by Serum Myo-inositol, Valine, Creatinine, and Cystatin-c Outperforms Current CKD-epi Equations in Renal Transplant Recipients
J. W. Meeusen¹, F. Stammler², J. Lieske³, M. Grassi², M. Shah⁴, E. Schiffer²
¹Cardiovascular Laboratory Medicine, Mayo Clinic, Rochester, MA, ²Research and Development, Numares, Boston, MA, ³Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ⁴Clinical Research, Numares, Boston, MA
*Purpose: Current estimated GFR (eGFR) equations using creatinine and/or cystatin C do no perform well in kidney transplant (KTx) recipients. Therefore, some large transplant programs…
2021 American Transplant Congress
Solid Organ Transplant Recipients and Healthcare Burden in Covid19 Era
A. Basu, N. Sharma, R. Subramanian, L. Sridharan, S. Pastan, T. Pearson
Emory Healthcare, Atlanta, GA
*Purpose: Pneumonia(PNA)- Acute inflammation of the lung parenchyma from an infection, is a frequent cause for hospitalization among Solid Organ Transplant Recipients (SOTRs), adversely effecting…
2021 American Transplant Congress
Risk Factors Associated with Severe COVID19 Illness in Kidney Transplant Recipients
E. Abuhelaiqa, M. Alkadi, H. Tohid, R. Elidrisi, R. Abdul Rahiman, M. F. Elshirbeny, T. A. Ghonaimi, A. I. Hamad, A. Nauman, A. A Aziz, O. Fituri, M. Asim, M. A. Othman, H. Al-Malki
Hamad Medical Corporation, Doha, Qatar
*Purpose: COVID19 is an acute respiratory infection that is caused by the SARS-COV-2 that has been shown to be highly contagious and poses a significant…
2021 American Transplant Congress
Impact of Valganciclovir Prophylaxis Dosing in High Risk Cytomegalovirus Kidney and Pancreas Transplant Recipients with Delayed Graft Function
A. Gharabagi¹, J. Geyston¹, A. Agarwal², S. Rao³, A. Doyle³, J. Dann¹
¹Pharmacy, University of Virginia Health System, Charlottesville, VA, ²Transplant Surgery, University of Virginia Health System, Charlottesville, VA, ³Transplant Nephrology, University of Virginia Health System, Charlottesville, VA
*Purpose: We sought to compare outcomes of cytomegalovirus (CMV) prophylaxis in high risk CMV (donor +/recipient -) kidney and pancreas transplant recipients who received different…
2021 American Transplant Congress
Sars-cov-2 versus Non-sars-cov-2 Infection Among Solid Organ Transplant Recipients: Case Control Study
M. A. Mendoza¹, M. Raja¹, S. Anjan¹, S. C. Curel², G. Rosello³, A. Fernandez¹, A. Chandorkar⁴, C. O'Brien⁵, A. Phancao⁵, N. Sinha¹, R. Vianna¹, M. Loebe¹, C. Gaetano¹, J. Simkins¹, M. Morris¹, L. Abbo¹, J. Camargo¹, G. Guerra¹, Y. Natori¹
¹Department of Medicine, University of Miami, Miami, FL, ²Miller School of Medicine, University of Miami, Miami, FL, ³University of Miami, Miami, FL, ⁴University of Minnesota, Minneapolis, MN, ⁵Miami Transplant Institute, University of Miami, Miami, FL
*Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been raging since the end of 2019. The clinical differences between non-SARS-CoV-2 coronavirus and SARS-CoV-2…
2021 American Transplant Congress
COVID-19 Infection in Kidney versus Non-kidney Solid Organ Transplant Recipients: A Single Center Study
J. Schaenman¹, H. Byford², T. R. Grogan³, S. Fraschilla², K. Meneses⁴, J. C. Alejos⁵, M. Rivera⁶, S. Saab⁷
¹Infectious Diseases, UCLA, Los Angeles, CA, ²Transplant Administration, UCLA, Los Angeles, CA, ³Division of General Internal Medicine and Health Services Research, UCLA, Los Angeles, CA, ⁴Liver Transplantation, UCLA, Los Angeles, CA, ⁵Pediatric Heart Transplantation, UCLA, Los Angeles, CA, ⁶Pediatric Kidney Transplantation, UCLA, Los Angeles, CA, ⁷Liver Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: The COVID-19 pandemic has caused significant morbidity and mortality in patients around the world. A significant impact has been observed in immunocompromised patients such…
2021 American Transplant Congress
Management of Asymptomatic Bacteriuria in Kidney Transplant Recipients
A. Diamond
Pharmacy, Temple University Hospital, Philadelphia, PA
*Purpose: Asymptomatic bacteriuria (ASB) is the presence of bacteriuria with no symptoms. Recent guidelines recommend against treatment of ASB in kidney transplant (KT) recipients more…
2021 American Transplant Congress
Risk Factors Associated with Multidrug Resistant Organism (MDRO) Infections in Kidney Transplant Recipients: A Single Center Experience
S. Schrank¹, J. Timpone², B. Javaid³, P. Kumar², M. Cooper³
¹Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, ²Infectious Diseases and Travel Medicine, MedStar Georgetown University Hospital, Washington, DC, ³Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Risk factors for MDRO infections in kidney transplant recipients have previously been studied but limited to urinary tract infections. We sought to evaluate the…
2021 American Transplant Congress
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience
M. Carter¹, M. Fitzmaurice², S. Yeddula², A. Singh², S. Nagai², S. Jafri²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Health System, Detroit, MI
*Purpose: Transplant-related Hepatitis E virus (HEV) infection is a rarely recognized entity with significant clinical importance given potential for chronic hepatitis post-transplant. We evaluated HEV…